Wells Fargo’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
RCM
ACA
JT
Wells Fargo's ASND Position: Q2 2026 in Review
Wells Fargo reduced its Ascendis Pharma A/S (ASND) stake by 67% in Q2 2026, selling an estimated $24.3M and leaving 50,353 shares worth $13.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1945.
Wells Fargo first reported a position in ASND in Q1 2015 and has held it in 40 quarters since. The position peaked at $55.2M in Q3 2021. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.
- Wells Fargo held 50,353 shares of Ascendis Pharma A/S worth $13.4M as of Q2 2026.
- Wells Fargo sold 103,846 Ascendis Pharma A/S shares in Q2 2026, an estimated $24.3M.
- Ascendis Pharma A/S made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #1945 holding.
- Wells Fargo first reported a position in Ascendis Pharma A/S in Q1 2015 and has held it in 40 quarters since.
- Wells Fargo's Ascendis Pharma A/S position peaked at $55.2M in Q3 2021.
- 313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.